The Next Generation of DCBs Is Here
A.N.T. is committed to solving vascular disease’s most significant challenges through the creative applications of nanotechnology.
Meet the incredible team behind A.N.T.
Marwan Berrada
M.Sc., MBA
Successful entrepreneur with extensive experience in cardiovascular and endovascular devices
Mehdi Shishehbor
DO, MPH, Ph.D.
Chief Medical Officer and President, Harrington Heart and Vascular Institute University Hospitals, Cleveland
Vinod Labhasetwar
Ph.D.
Professor and Endowed Chair of Nanomedicine, Department of Biomedical Engineering at Cleveland Clinic Lerner Research
Michael Mandel
MBA
Head of Corporate Development, Experienced medical technology investment banking professional
Prominent Scientific Advisory Board
Azeem Latib, MD
Director, Interventional Cardiology & Structural Heart Interventions, Montefiore Medical Center
Gary Ansel, MD, FACC
System Medical Chief, Vascular Program, OhioHealth
Peter Schneider, MD
Professor of Surgery, Div. of Vascular & Endovascular Surgery, UCSF
Sahil Parikh, MD
Director of Endovascular Services, NewYork-Presbyterian / Columbia University, Irving Medical Center
Mahmood Razavi, MD
Radiology and Vascular and Interventional Radiology, Children’s Health Orange County
Thomas Zeller, MD
Associate Professor in the Angiology Division, Universitaets-Herzzentrum, Freiburg, Bad Krozingen, Germany
Renu Virmani, MD
President of CVPath Institute
Aloke Finn, MD
Medical Director, CVPath Institute and Associate Professor of Medicine, University of Maryland